
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
LRP6 CRISPR/Cas9 KO Plasmid (m2) | sc-421466-KO-2 | 20 µg | $397.00 | |||
LRP6 HDR Plasmid (m2) | sc-421466-HDR-2 | 20 µg | $445.00 |
Mouse Lrp6 encodes low-density lipoprotein receptor-related protein 6 (LRP6), a coreceptor essential for canonical Wnt/β-catenin signaling. Upon Wnt ligand engagement with Frizzled, LRP6 phosphorylation promotes β-catenin stabilization and transcriptional programs controlling proliferation, differentiation, and tissue patterning. LRP6 also interfaces with endocytosis and receptor trafficking and can modulate pathway cross-talk affecting cytoskeletal dynamics and metabolic regulation. Dysregulated LRP6-dependent Wnt signaling has been linked to developmental abnormalities and altered homeostatic signaling in contexts relevant to bone, neurobiology, and oncogenic pathway remodeling.
LRP6 CRISPR/Cas9 KO Plasmid (m2) is a pool of plasmids designed for targeted disruption of the Lrp6 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Lrp6 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, LRP6 HDR Plasmid (m2) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Lrp6 target site.
When co-transfected with LRP6 CRISPR/Cas9 KO Plasmid (m2):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Lrp6 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.